Title: Glepaglutide, a novel glucagon-like peptide-2 agonist, has anti-inflammatory and mucosal
regenerative effects in an experimental model of inflammatory bowel disease in rats
Version: 3 Date: 10 Feb 2023
Reviewer's report:
the authors responded comprehensively to the reviewers' requests by making significant changes
to the manuscript.
I consider the work done to be satisfactory and I believe that the paper is ready for publication.
Title: Glepaglutide, a novel glucagon-like peptide-2 agonist, has anti-inflammatory and mucosal
regenerative effects in an experimental model of inflammatory bowel disease in rats
Version: 3 Date: 10 Feb 2023
Reviewer's report:
the authors responded comprehensively to the reviewers' requests by making significant changes
to the manuscript.
I consider the work done to be satisfactory and I believe that the paper is ready for publication.
Please review this paper.
user
Title: Glepaglutide, a novel glucagon-like peptide-2 agonist, has anti-inflammatory and mucosal
regenerative effects in an experimental model of inflammatory bowel disease in rats
Version: 3 Date: 10 Feb 2023
Reviewer's report:
the authors responded comprehensively to the reviewers' requests by making significant changes
to the manuscript.
I consider the work done to be satisfactory and I believe that the paper is ready for publication.
assistant